−0.110SEK
−4.40 MSEK
21.72 M
About PHARMALUNDENSIS AB
Sector
CEO
Staffan Skogvall
Headquarters
Lund
Website
Founded
2006
ISIN
SE0003359710
FIGI
BBG001Y25XV3
PharmaLundensis AB engages in the provision of biotechnology activities. It offers research and development of medicines and treatment for lung diseases such as chronic obstructive pulmonary disease, chronic bronchitis, and influenza. The company was founded by Staffan Skogvall in 2006 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PHAL is 0.734 SEK — it has increased by 1.66% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange PHARMALUNDENSIS AB stocks are traded under the ticker PHAL.
PHAL stock is 1.63% volatile and has beta coefficient of 1.93. Check out the list of the most volatile stocks — is PHARMALUNDENSIS AB there?
Yes, you can track PHARMALUNDENSIS AB financials in yearly and quarterly reports right on TradingView.
PHAL stock has risen by 4.56% compared to the previous week, the month change is a 5.90% fall, over the last year PHARMALUNDENSIS AB has showed a 9.55% increase.
PHAL net income for the last quarter is −1.53 M SEK, while the quarter before that showed −1.07 M SEK of net income which accounts for −43.01% change. Track more PHARMALUNDENSIS AB financial stats to get the full picture.
Today PHARMALUNDENSIS AB has the market capitalization of 39.18 M, it has increased by 4.12% over the last week.
No, PHAL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PHAL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMALUNDENSIS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMALUNDENSIS AB technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMALUNDENSIS AB stock shows the buy signal. See more of PHARMALUNDENSIS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.